United Therapeutics had a net margin of 40.31% and a return on equity of 19.22%. The company had revenue of $735.90 million for the quarter, compared to the consensus estimate of $734.74 million.

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., March 04, 2025--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that ...

Bilas is sticking with Florida and Duke as the best teams in the NCAA Tournament. Bilas doesn't see the Cats and Vols being determined by each team's veteran point guards. His key to the game may ...

Investors in United Therapeutics Corp (Symbol: UTHR) saw new options become available this week, for the November 21st expiration. One of the key inputs that goes into the price an option buyer is ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Wollongong has entered party mode as the Illawarra Hawks crushed Melbourne United in a game five classic to become NBL champions for the second time in history. Illawarra Hawks have climbed back ...

In an alternate universe, Melbourne United would be celebrating a third NBL championship in four years – but once again have been left to pick up the pieces. Here’s how they blew their chance.

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of unique products to address the unmet medical needs of patients with chronic ...